Patent · US Active

Treatment for anxiety

US8008253B2 · kind B2 · utility

5Cited by

1References

34Claims

0Family size

Inventors

Andrew Tasker · Charlottetown, CA
Tracy Doucette · Coaticook, CA
Michael Tymianski · Toronto, CA
Kenneth A. Mendoza · Oakland, US
Michael P. Belmares · San Jose, US
David Garman · Fawn Drive, AU
Peter S. Lu · Palo Alto, US

Key dates

Filing date	Jul 1, 2008
Grant date	Aug 30, 2011
Priority date	—
Expiry date	Jan 26, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides methods of treating or effecting prophylaxis of a patient having or at risk of developing symptoms of anxiety in which an effective regime of an agent that inhibits specific binding of PSD95 to an NMDA receptor is administered to a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.